Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11245430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular determinants of response to TRAIL in killing of normal and cancer cells.

  2000cited by this paper
• Mitotic misregulation and human aging.

  2000cited by this paper
• Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.

  2000cited by this paper
• Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

  2000cited by this paper
• The structural and mechanical complexity of cell-growth control

  1999cited by this paper
• EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.

  1999cited by this paper
• Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.

  1999cited by this paper
• Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes.

  1999cited by this paper
• Integrin signaling.

  1999cited by this paper
• The TRAIL to selective tumor death

  1999cited by this paper
• Upregulation of human heme oxygenase gene expression by Ets‐family proteins

  1999cited by this paper
• De‐regulation of GRP stress protein expression in human breast cancer cell lines

  1999cited by this paper
• Genetic dissection of dome formation in a mammary cell line: identification of two genes with opposing action.

  1999cited by this paper
• Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5.

  1999cited by this paper
• Alpha E beta 7.

  1999cited by this paper
• Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

  1998cited by this paper
• Expression of the 150-kd oxygen-regulated protein in human breast cancer.

  1998cited by this paper
• The proofreading domain of Escherichia coli DNA polymerase I and other DNA and/or RNA exonuclease domains.

  1997cited by this paper
• Tamoxifen induces TGF‐β1 activity and apoptosis of human MCF‐7 breast cancer cells in vitro

  1996cited by this paper
• Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.

  1996cited by this paper
• A cohort of supporting metabolic enzymes is coinduced with nitric oxide synthase in human tumor cell lines.

  1996cited by this paper
• 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells.

  1996cited by this paper
• Mycosis fungoides with extracutaneous localization in the breast

  1996cited by this paper
• Transport of UDP-Galactose into the Golgi Lumen Regulates the Biosynthesis of Proteoglycans (*)

  1996cited by this paper
• Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.

  1996cited by this paper
• Tumor necrosis factor–alpha modulates CCAAT/enhancer binding proteins–DNA binding activities and promotes hepatocyte‐specific gene expression during liver regeneration

  1995cited by this paper
• Mat-8, a Novel Phospholemman-like Protein Expressed in Human Breast Tumors, Induces a Chloride Conductance in Xenopus Oocytes (*)

  1995cited by this paper
• Involvement of the polyamine pathway in breast cancer progression.

  1995cited by this paper
• The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth.

  1992cited by this paper
• Antiproliferative activity of L-asparaginase of Tetrahymena pyriformis on human breast cancer cell lines

  1990cited by this paper

• Targeting the Akt–EphA2 axis and cell–cell adhesion enhances anoikis sensitivity in cancer cells

  2026cites this paper
• TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms

  2020cites this paper
• Environmental control of mammary carcinoma cell expansion by acidification and spheroid formation in vitro

  2020cites this paper
• Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer

  2016cites this paper
• Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons

  2016cites this paper
• TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

  2016cites this paper
• Neobavaisoflavone sensitizes apoptosis via the inhibition of metastasis in TRAIL-resistant human glioma U373MG cells.

  2014cites this paper
• Regulation of the expression of CLU isoforms in endometrial proliferative diseases.

  2013cites this paper
• Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis

  2012cites this paper
• Targeting Cell Spreading: A Method of Sensitizing Metastatic Tumor Cells to TRAIL-Induced Apoptosis

  2011cites this paper
• Angiogenesis , Metastasis , and Tumor Micronenvironment Targeting Cell Spreading : A Method of Sensitizing Metastatic Tumor Cells to TRAIL-Induced Apoptosis

  2011cites this paper
• Apoptosis: Physiology and Pathology

  2011cites this paper
• Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents

  2010influential citation
• Chapter 5: Nuclear CLU (nCLU) and the fate of the cell.

  2009cites this paper
• Involvement of anoikis-resistance in the metastasis of hepatoma cells.

  2009cites this paper
• Bisnaphthalimidopropyl spermidine induces apoptosis within colon carcinoma cells.

  2009cites this paper
• Metastasis suppressor function of TRAIL-R in mice-implications for TRAIL-based therapy in humans ?

  2009cites this paper
• DR 5 Receptor Mediates Anoikis in Human Colorectal Carcinoma Cell Lines

  2008influential citation
• TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

  2008cites this paper
• Vaccinia Virus WR53.5/F14.5 Protein Is a New Component of Intracellular Mature Virus and Is Important for Calcium-Independent Cell Adhesion and Vaccinia Virus Virulence in Mice

  2008cites this paper
• DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.

  2008cites this paper
• Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans?

  2008cites this paper
• Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.

  2007cites this paper
• Apoptosis chip for drug screening

  2007cites this paper
• Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling.

  2007cites this paper
• Primary hepatocyte survival on non-integrin-recognizable matrices without the activation of Akt signaling.

  2007cites this paper
• Individual Cas Phosphorylation Sites Are Dispensable for Processive Phosphorylation by Src and Anchorage-independent Cell Growth*

  2006cites this paper
• SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.

  2006cites this paper
• Clusterin Expression and Univariate Analysis of Overall Survival in Human Breast Cancer

  2006cites this paper
• Clusterin: the missing link in the calcium-dependent resistance of cancer cells to apoptogenic stimuli.

  2006cites this paper
• Death Signaling and Therapeutic Applications of TRAIL

  2005cites this paper
• Molecular targets of doxazosin in human prostatic stromal cells

  2005cites this paper
• Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis.

  2005cites this paper
• Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin.

  2004cites this paper
• Normal Cells Control the Growth of Neighboring Transformed Cells Independent of Gap Junctional Communication and Src Activity

  2004cites this paper
• Progranulin (granulin-epithelin precursor, PC-cell derived growth factor, acrogranin) in proliferation and tumorigenesis.

  2003cites this paper
• Nuclear Translocation of a Clusterin Isoform Is Associated with Induction of Anoikis in SV40‐Immortalized Human Prostate Epithelial Cells

  2003cites this paper
• Src Phosphorylates Cas on Tyrosine 253 to Promote Migration of Transformed Cells*

  2003cites this paper
• Enhanced Sensitivity of G1 Arrested Human Cancer Cells Suggests a Novel Therapeutic Strategy Using a Combination of Simvastatin and TRAIL

  2002cites this paper
• Skeletal muscle denervation increases satellite cell susceptibility to apoptosis.

  2002cites this paper
• Clusterin/apolipoprotein J in human aging and cancer.

  2002cites this paper
• Role of innate immunity in cancer.

  2001cites this paper
• Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

  2001cites this paper
• Potential and caveats of TRAIL in cancer therapy.

  2001cites this paper
• Advances in Brief Mutations of Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor 1 ( TRAIL-R 1 ) and Receptor 2 ( TRAIL-R 2 ) Genes in Metastatic Breast Cancers 1

  2001cites this paper